Knowtex is thrilled to announce its partnership with Pennsylvania Cancer Specialists & Research Institute (PCSRI), a collaboration dedicated to advancing artificial intelligence in oncology workflows. This partnership drives the development of custom AI models tailored to oncologists, enhancing clinical workflows and supporting comprehensive, patient-centered care.
In today’s healthcare landscape, efficient and accurate documentation and coding are essential to delivering high-quality care. This partnership with PCSRI focuses on creating detailed, accurate, medically relevant notes and coding custom built for oncology, and also pioneers intelligent follow-up note synthesis capabilities that seamlessly integrate with Electronic Medical Records (EMR), equipping PCSRI’s oncologists with actionable insights for long-term, longitudinal care.
This novel AI-driven approach aims to streamline documentation processes, ensuring that oncology notes are both accurate and enriched with synthesized follow-up information. By integrating these insights directly into the EMR, clinicians can track patient journeys over time with a level of detail that supports personalized, data-informed decisions and have a seamless workflow.
Knowtex and PCSRI are dedicated to pioneering healthcare solutions that support real-world improvements in patient care and oncology care. Through this partnership, we aim to deliver technology that empowers providers and positively impacts the lives of cancer patients.
Pennsylvania Cancer Specialists & Research Institute (PCSRI), a partner of the One Oncology Network, is dedicated to providing a caring environment for patients and their families with all-encompassing oncology and hematology programs that provide a complete range of diagnosis, treatment, and follow-up care. Our mission is to provide individualized treatment, utilizing the best technical approach, and recognizing each patient’s psychological, emotional, and spiritual needs during their journey with their illness and healing.
.png)
